473 Autofluorescence Assessment in the Surveillance of Barrett's Oesophagus: A Randomised Trial Comparing Standard 4 Quadrant Biopsy and AF Directed Biopsy
“…New methods for targeted biopsy are being sought to replace random biopsy; it is anticipated that targeted biopsy will detect more dysplasia and more advanced dysplasia using fewer tissue samples. Candidate methods include autofluor− escence imaging [1], confocal laser endomicros− copy [2,3], and high−resolution endoscopy with narrow−band imaging (NBI) [4]. Selected studies on this topic are summarized in l " Table 1.…”
Section: Diagnosis Of Cancer and Precancerous Lesions !mentioning
“…New methods for targeted biopsy are being sought to replace random biopsy; it is anticipated that targeted biopsy will detect more dysplasia and more advanced dysplasia using fewer tissue samples. Candidate methods include autofluor− escence imaging [1], confocal laser endomicros− copy [2,3], and high−resolution endoscopy with narrow−band imaging (NBI) [4]. Selected studies on this topic are summarized in l " Table 1.…”
Section: Diagnosis Of Cancer and Precancerous Lesions !mentioning
“…Over the past several years, various advanced imaging techniques have been devel− oped in order to better detect dysplasia within Barrett's esopha− gus and improve the yield of surveillance biopsies. McCallum and colleagues presented the results of a randomized crossover trial in which upper endoscopies were performed 2 months apart [34]. On one endoscopy (the order being random), random four−quadrant biopsies were performed as per the Seattle proto− col using standard−resolution white−light endoscopy (WLE).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.